Dr. Pollock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 West 10th Avenue, Suite D920
Columbus, OH 43210Phone+1 614-293-7171
Summary
- Raphael E. Pollock, MD, PhD, Dr. Pollock joined the faculty of the University of Texas MD Anderson Cancer Center in 1984 upon completion of fellowship training at that institution. In 1993 Dr. Pollock began service as Chairman of the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center, a position that he held until 2010. In 1996, service as Head of the Division of Surgery at the University of Texas MD Anderson Cancer Center was begun, a position entailing supervisory relationships with all seven surgical specialty departments at that institution. In 2013 Dr. Pollock was recruited to The Ohio State University as Professor and Director of the Division of Surgical Oncology and Chief of Surgical Services at the James Comprehensive Cancer Center. This was followed by appointment in 2015 as Surgeon in Chief, the James Comprehensive Cancer Center and Surgeon in Chief, The Ohio State University Health System. In 2017, Dr. Pollock was appointed to his current position as Professor and Director, The Ohio State University Comprehensive Cancer Center.
Dr. Pollock’s clinical and laboratory research work focuses on soft tissue sarcoma, a rare tumor system of connective tissue origin.
Education & Training
- University of Texas Health Science Center at HoustonPh.D., 1990
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 1982 - 1984
- Rush University Medical CenterResidency, Surgery, 1980 - 1982
- University of ChicagoResidency, Surgery, 1977 - 1980
- Saint Louis University School of MedicineClass of 1977
- Oberlin CollegeBA, History, High Honors, 1972
Certifications & Licensure
- OH State Medical License 2013 - 2026
- TX State Medical License 1985 - 2015
- IL State Medical License 1978 - 1987
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2020
- Daniel M. Miller Distinguished Lecturer University of Nebraska, 2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms Start of enrollment: 2006 Nov 01
- REtroperitoneal SArcoma Registry: an International Prospective Initiative Start of enrollment: 2016 Sep 01
Publications & Presentations
PubMed
- 46 citationsDurable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liverGiora M. Mavligit, Raphael E. Pollock, Harry L. Evans, Sidney Wallace
Cancer. 1993-07-15 - 46 citationsDiagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis.Markus P. Ghadimi, Tariq Al-Zaid, John E. Madewell, Tingsheng Peng, Chiara Colombo
Annals of Surgical Oncology. 2011-05-26 - 610 citationsSoft Tissue SarcomasJanice N. Cormier, Raphael E. Pollock
CA. 2004-03-01
Journal Articles
- Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient SurvivalAlexander J Lazar, Joseph A Ludwig, Cynthia E Herzog, Raphael E Pollock, Clinical Cancer Research
- Histone deacetylase inhibition for the treatment of epithelioid sarcoma; novel cross talk between epigenetic componentsSong Y, Lopez G, Lam R, Ruder D, Creighton C, Bid HK, Bolshakov S, Zhang X, Lev D, Pollock RE, Mol Cancer Res, 1/1/2016
- Radiation-associated undifferentiated pleomorphic sarcoma is associated with worse clinical outcomes compared to sporadic lesionsDineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Al Sannaa G, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, To..., Ann Surg Onc, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Surgical stress generation of suppressor cells which impair natural killer cell cytotoxicityPollock RE, Lotzova E, Stanford D, Romsdahl M, American Association for Cancer Research, Houston, TX, 1/1/1985
- Soft tissue sarcomas of the shoulder: factors influencing local recurrence, distant metastases, and survivalMeterissian SH, Reilly JA, Murphy A, Romsdahl MM, Pollock RE, Society Surgical Oncology, Houston, TX, 1/18/1994
- Splenic natural killer cell cytotoxicity (NKCC) can be augmented in patients with leukemiaPollock RE, Savary C, Lotzova E, American Association for Cancer Research, Washington, DC, 1/24/1990
- Join now to see all
Lectures
- From the clinic to the corner officeColumbus, OH - 1/29/2016
- New research perspectives in soft tissue sarcomaNationwide Children’s Hospital, Columbus, OH - 1/1./2016
- Management of localized soft tissue sarcomaMilan, Italy - 1/15/2016
- Join now to see all
Press Mentions
- Bridget Oppong Tapped as Deputy Director of Ohio State's Center for Cancer Health EquityNovember 30th, 2021
- Ohio State Offering Additional COVID-19 Shot for Immunocompromised PeopleAugust 17th, 2021
- Doubling down: Pelotonia Plans to Increase Fundraising to $50 Million Annually by 2026June 30th, 2021
- Join now to see all
Grant Support
- Soft Tissue Sarcoma--P53 And VEGF InductionNational Cancer Institute2000–2004
- Training Of Academic Surgical OncologistsNational Cancer Institute1996–1999
- Therapy And Biological Correlates Of Soft-Tissue SarcomaNational Cancer Institute1995–1998
- NK Cell Genesis From Human Bone Marrow ProgenitorsNational Cancer Institute1993–1994
- Surgical Stress Impairment Of Human NK Cell CytotoxicityNational Cancer Institute1990–1994
- Natural Killer Cell--Toxicology Following SurgeryNational Cancer Institute1988
- Chem Study Of Natl Killer Cell TOX Following Surg StressNational Cancer Institute1987
- Physician-Investigator Development Award ProgramNational Cancer Institute1985–1986
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: